Avance Clinical to Showcase its Early Phase Center of Excellence Model at AusBiotech International 2026

Adelaide, Australia — Friday 16 October 2026

Avance Clinical, the Australian-headquartered global contract research organization (CRO) specializing in Early Phase and First-in-Human trials for biotechs across North America, Asia Pacific and Europe, will exhibit at Stand #72 at the AusBiotech International Conference 2026. The conference runs 21–23 October 2026 at the Gold Coast Convention and Exhibition Centre, Queensland, as part of Australia’s Biggest Week in Biotech (19–23 October).

AusBiotech International is one of the largest biotechnology gatherings in the Southern Hemisphere. In 2025 it drew participants from more than 23 countries. Avance Clinical says this international reach signals Australia’s growing role as a strategic node in how global biotechs sequence their development pathway.

For more than 30 years, Avance Clinical has led early phase trial delivery in Australia and New Zealand. The company has partnered with more than 750 emerging biotech companies across more than 250 indications. Over that time, the questions sponsors ask have changed markedly. Offshore biotechs continue to prioritise access: healthy volunteer availability, ethics committee approval and cost efficiency. Additionally, sponsors ask more sophisticated questions: not simply how quickly a trial can start, but how quickly can I receive topline data and how much execution risk can be removed across the full Phase I-to-Phase II arc.